How much funding has InventisBio raised?

InventisBio has raised $247.0M in total funding, most recently a Series D round.

Who are InventisBio's investors?

InventisBio's investors include OrbiMed, Hillhouse Capital, Advantech Capital, CMBI, Lilly Asia Ventures, Qiming VP.

When was InventisBio founded?

InventisBio was founded in 2013.

Where is InventisBio headquartered?

InventisBio is headquartered in Shanghai, China.

What industry is InventisBio in?

InventisBio operates in Biotech, Life Sciences, Drug Discovery, Healthcare.

How many employees does InventisBio have?

InventisBio has 11-50 employees.

InventisBio

IPO

益方生物科技（上海）股份有限公司

Public · Shanghai, China · Founded 2013 · $247.0M raised

Headquarters: Shanghai
Employees: 11–50
Founded: 2013
Business Model: B2B
Website: inventisbio.com

Total Funding: $247.0M
Last Round: $147.0M Series DSep 2020
Rounds: 4
Type: Public

About

InventisBio is a clinical-stage biotech company with two drugs approved and three candidates in clinical trials, with the most advanced in Phase 3 registration trials in China. Founded by scientists with extensive R&D experience at global pharmaceutical companies, the firm focuses on oncology, metabolic, and autoimmune diseases to address unmet medical needs, with headquarters in Shanghai Pudong and operations in New Jersey.

Summary

InventisBio is a Biotech company based in Shanghai, China, founded in 2013. It has raised $247.0M in total across 4 rounds, most recently a $147.0M Series D round in Sep 2020. Investors include OrbiMed, Hillhouse Capital and Advantech Capital.